Tenax Therapeutics, Inc. stock is up 81.87% since 30 days ago. The next earnings date is Apr 1, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 60% of the previous 9 December’s closed higher than November. 100% of analysts rate it a buy.
Tenax Therapeutics, Inc. engages in identifying, developing, and commercializing products for cardiovascular and pulmonary diseases in the United States and Canada. The company was founded in 1967 and is headquartered in Morrisville, North Carolina.